Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Multi-Omic Analyses of the m5C Regulator ALYREF Reveal Its Essential Roles in Hepatocellular Carcinoma
Chen Xue, Yalei Zhao, Ganglei Li, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

ALYREF mediates RNA m5C modification to promote hepatocellular carcinoma progression
Chen Xue, Xinyu Gu, Qiuxian Zheng, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 39
Detection, molecular function and mechanisms of m5C in cancer
Linhui Zhang, Yuelong Li, Liqing Li, et al.
Clinical and Translational Medicine (2025) Vol. 15, Iss. 3
Open Access | Times Cited: 1
ALYREF, a novel factor involved in breast carcinogenesis, acts through transcriptional and post-transcriptional mechanisms selectively regulating the short NEAT1 isoform
Christiane Klec, Erik Knutsen, Daniela Schwarzenbacher, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 7
Open Access | Times Cited: 33
The Mechanism Underlying the ncRNA Dysregulation Pattern in Hepatocellular Carcinoma and Its Tumor Microenvironment
Chen Xue, Xinyu Gu, Zhengyi Bao, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 32
Vital roles of m5C RNA modification in cancer and immune cell biology
Xinyu Gu, Xiao Ma, Chao Chen, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 21
ALYREF-mediated RNA 5-Methylcytosine modification Promotes Hepatocellular Carcinoma Progression Via Stabilizing EGFR mRNA and pSTAT3 activation
Jiayida Nulali, Kaiwen Zhang, Manmei Long, et al.
International Journal of Biological Sciences (2023) Vol. 20, Iss. 1, pp. 331-346
Open Access | Times Cited: 17
Identification of ALYREF in pan cancer as a novel cancer prognostic biomarker and potential regulatory mechanism in gastric cancer
Yujie Yuan, Yiyang Fan, Wenqing Tang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Roles of m5C RNA Modification Patterns in Biochemical Recurrence and Tumor Microenvironment Characterization of Prostate Adenocarcinoma
Zhipeng Xu, Shuqiu Chen, Yuxi Zhang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 24
The role of RNA modification in hepatocellular carcinoma
Qiang Feng, Dongxu Wang, Tianyi Xue, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 23
Structural basis for high-order complex of SARNP and DDX39B to facilitate mRNP assembly
Yihu Xie, Shengyan Gao, Ke Zhang, et al.
Cell Reports (2023) Vol. 42, Iss. 8, pp. 112988-112988
Open Access | Times Cited: 14
Multi-omic analyses of m5C readers reveal their characteristics and immunotherapeutic proficiency
Rui Xu, Yue Wang, Ye Kuang
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
An evolutionary learning-based method for identifying a circulating miRNA signature for breast cancer diagnosis prediction
Srinivasulu Yerukala Sathipati, Ming‐Ju Tsai, Nikhila Aimalla, et al.
NAR Genomics and Bioinformatics (2024) Vol. 6, Iss. 1
Open Access | Times Cited: 5
Integrative analysis of 5-methylcytosine associated signature in papillary thyroid cancer
Ying Ding, Xinying Li, Wenlong Wang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
ETV4/ALYREF-mediated glycolytic metabolism through PKM2 enhances resistance to ferroptosis and promotes the development of intrahepatic cholangiocarcinoma
Xiaohui Wang, Wenbin Duan, Zhongzhi Ma, et al.
Cancer & Metabolism (2025) Vol. 13, Iss. 1
Open Access
Deciphering the vital roles and mechanism of m5C modification on RNA in cancers.
Lemei Zheng, Yumei Duan, Mengna Li, et al.
PubMed (2023) Vol. 13, Iss. 12, pp. 6125-6146
Closed Access | Times Cited: 9
The impact of epitranscriptomic modifications on liver disease
Keith A. Berggren, Robert E. Schwartz, Ralph E. Kleiner, et al.
Trends in Endocrinology and Metabolism (2024) Vol. 35, Iss. 4, pp. 331-346
Closed Access | Times Cited: 3
RNA m5C methylation: a potential modulator of innate immune pathways in hepatocellular carcinoma
Sun Meng, Bai Jiangtao, Wang Haisong, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Diagnostic and prognostic value of m5C regulatory genes in hepatocellular carcinoma
Xiawei Yang, Feng Yang, Liugen Lan, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 14
More than a duologue: In-depth insights into epitranscriptomics and ferroptosis
Justin Chak Ting Cheung, Guangzheng Deng, Nathalie Wong, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 13
Targeting neuroblastoma by small-molecule inhibitors of human ALYREF protein: mechanistic insights using molecular dynamics simulations
Nidhi Goswami, Archana Singh, Shiv Bharadwaj, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 3, pp. 1352-1367
Closed Access | Times Cited: 8
Non-coding RNA methylation modifications in hepatocellular carcinoma: interactions and potential implications
Qingmiao Shi, Qingfei Chu, Yifan Zeng, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 8
ALYREF associated with immune infiltration is a prognostic biomarker in hepatocellular carcinoma
Zhenzhen Wang, Tao Meng, Mingya Yang, et al.
Translational Oncology (2022) Vol. 21, pp. 101441-101441
Open Access | Times Cited: 12
Clinical significance of RNA methylation in hepatocellular carcinoma
Qiongling Bao, Yifan Zeng, Qizhuo Lou, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2
Development and validation of a novel prognostic signature based on m6A/m5C/m1A-related genes in hepatocellular carcinoma
Yu Xiao, Jinluan Li, Junxin Wu
BMC Medical Genomics (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 6
The Key Role of RNA Modification in Breast Cancer
Yang Liu, Tong Zhu, Yi Jiang, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top